A regional prospective survey of RSV bronchiolitis;Étude prospective régionale d'une épidémie de bronchiolites à virus respiratoire syncytial (VRS)

Archives de Pediatrie

Volumn 9, Issue 6, 2002, Pages 572-580

  Grimaldi, M ^a   Cornet, B ^b   Milou, C ^a   Gouyon, J B ^a  

^a Medical University of Dijon   (France)

^b DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Bronchiolitis; Child; Hospitalization; Human antibodies; Monoclonal; Respiratory syncitial virus; Risk factors

Indexed keywords

MONOCLONAL ANTIBODY; VIRUS ANTIBODY;

ANAMNESIS; ARTICLE; ARTIFICIAL VENTILATION; BRONCHIOLITIS; CHILD DEATH; CONGENITAL HEART DISEASE; FEMALE; FRANCE; GESTATIONAL AGE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFANT; INFECTION RISK; INTENSIVE CARE; LENGTH OF STAY; LOW BIRTH WEIGHT; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; PREMATURITY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RISK ASSESSMENT; RISK FACTOR; TREATMENT INDICATION; TREATMENT PLANNING; CONGENITAL HEART MALFORMATION; EPIDEMIC; NEWBORN; PATHOGENICITY; PROSPECTIVE STUDY; STATISTICS; VIRUS INFECTION;

ANTIBODIES, MONOCLONAL; BRONCHIOLITIS; BRONCHOPULMONARY DYSPLASIA; DISEASE OUTBREAKS; FEMALE; HEART DEFECTS, CONGENITAL; HOSPITALIZATION; HUMANS; INFANT; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INTENSIVE CARE UNITS, PEDIATRIC; MALE; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RISK FACTORS;

EID: 0036593388     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(01)00923-X     Document Type: Article

References (43)

1. Bronchiolites aiguës
2. Epidémiologie clinique et virologique de la bronchiolite du nourrisson. Enquête nationale multicentrique
3. Epidémiologie de la bronchiolite du nourrissson en France. Conférence de consensus
4. Bronchiolitis-associated hospitalizations among US children, 1980-1996
5. Risk of primary infection and reinfection with respiratory syncytial virus
6. National surveillance for respiratory syncytial virus, United States, 1985-1990
7. The etiologic and epidemiologic spectrum of bronchiolitis in pediatric practice
8. Rehospitalization for respiratory illness in infants of less than 32 weeks' gestation
9. Rehospitalization because of respiratory syncytial virus infection in premature infants younger than 33 weeks of gestation: A prospective study
10. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia
11. Rehospitalization for respiratory syncytial virus among premature infants
12. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants
13. Respiratory syncytial virus and premature infants born at 32 weeks' gestation or earlier
14. Pediatric investigators Collaborative Network on Infections in Canada (PICNIC); prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial virus lower respiratory tract disease
15. Respiratory syncytial virus infection
16. Respiratory syncytial virus infections in hospitalized Canadian children: Regional differences in patient populations and management practices
17. Outpatient assessment of infants with bronchiolitis
18. Risk factors for respiratory syncytial virus associated apnea
19. Severity of illness models for respiratory syncytial virus associated hospitalization
20. Respiratory Syncytial virus morbidity and mortality estimates in congenital heart disease patients: A recent experience
21. Respiratory syncytial virus infection in children with compromised immune function
22. Surveillance épidémiologique hospitalière de la bronchiolite du nourrissson par le réseau ERBUS
23. Aspects thérapeutiques de la bronchiolite du nourrisson, à l'exclusion de la corticothérapie et des bronchodilatateurs. Conférence de consensus
24. Treatment and prevention of respiratory syncytial virus infection
25. Management strategies for respiratory syncytial virus infections in infants
26. Advances in prevention of respiratory syncytial virus infection
27. Prevention of respiratory syncytial virus (RSV) infection: RSV immune globulin intravenous and palivizumab
28. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis
29. Palivizumab
30. Respiratory syncytial virus (RSV) immune globulin and palivizumab for prevention of RSV infection
31. Prevention of respiratory syncytial virus infections. Indications for the use of palivizumab and update on the use of RSV-IGIV
32. Prévention de la bronchiolite. Mesures à prendre dans les familles? Au cabinet? Dans les services hospitaliers? Modes de garde à proposer aux enfants
33. Cost-effectiveness of respiratory syncytial virus prophylaxis among preterm infants
34. Humanized monoclonal antibody for prevention of respiratory syncytial virus infection
35. Nosocomial respiratory syncytial virus infection in Canadian pediatric hospitals: A pediatric investigators collaborative network on infections in Canada study
36. Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid
37. PMSI et évaluation en périnatalité: Faisabilité-chaînage des données
38. Hospitalization rates for respiratory syncytial virus infection in premature infants born during two consecutive seasons
39. Development of local guidelines for prevention of respiratory syncyial viral infections